Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. serves customers who are accelerating life sciences research, solving complex analytica... read more Featured Products: More products

Download Mobile App




Glycated Albumin Is a Promising Marker for Diabetes

By LabMedica International staff writers
Posted on 30 Nov 2015
Although glucose level is the contributing factor and diagnostic marker for type 2 diabetes, there is an imperative need to look “beyond glucose” and to seek additional biomarkers that could better predict the risk for diabetes as well its diagnosis with accurate precision. More...


Human serum albumin is one of the most abundant plasma proteins that readily undergoes glycation, thus glycated albumin has been suggested as an additional marker for monitoring glycemic status in people with type 2 diabetes.

Scientists at the National Chemical Laboratory (Pune, India) collected blood samples from a diabetes specialized clinic as well as healthy controls. Diagnostic parameters, including fasting blood glucose, HbA1c, oral glucose tolerance test, postprandial blood sugar, lipids, urea, creatinine, and microalbumin were measured. Equal volumes of two plasma samples with similar HbA1c (deviation of less than 0.2%) were pooled, and three such pooled plasma in each group were used for mass spectrometric technical triplicate analysis.

The team used high resolution accurate mass spectrometry (HR/AM) which has paved the way for the fragment ion library that was used for quantification of glycated peptides of albumin in the context of diabetes. Glycation is a non-enzymatic chemical reaction between glucose and proteins leading to formation of advanced glycation end products (AGEs), which have been implicated in the pathogenesis of type 2 diabetes and its complications. All samples were analyzed on hybrid quadruple Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific; Waltham, MA, USA).

Muthuswamy Balasubramanyam, PhD, senior author of the study said, “While earlier studies quantified only Amadori-modified lysine (AML) modifications, our study in addition characterized the carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) modified peptides of albumin and this is an important advancement as CML and CEL are the predominant AGEs, constituting up to 80% of total AGEs. The association of CML modified peptides of albumin with prediabetes, diabetes, and microalbuminuria is a clinically relevant and therapeutically important finding.” The study was published originally online on August 1, 2015, in the journal Molecular Cell Proteomics.

Related Links:

National Chemical Laboratory 
Thermo Scientific 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.